
Double funding boost to support sudden cardiac death and heart failure research

Congratulations to Dr Tamim Akbari, a clinical research fellow at Royal Brompton Hospital, who has been awarded two research grants from the British Medical Association (BMA).
The funding will enable Dr Akbari to undertake two research projects over a three-year period while continuing his clinical work. The projects are supported by the BMA’s Josephine Lansdell Grant, which funds research in heart disease, and the J Moulton Grant, which aims to accelerate the diagnosis and treatment of heart disease using artificial intelligence (AI) techniques.
Both projects focus on dilated cardiomyopathy (DCM), a leading cause of heart failure.
In people with DCM, the heart’s main pumping chamber, known as the left ventricle, becomes enlarged and weakened. This reduces the heart’s ability to pump blood effectively around the body and can lead to serious complications, including heart failure and abnormal heart rhythms.
DCM affects around 1 in 250 people and, despite advances in treatment, is associated with a five-year mortality rate of approximately 20%. Patients with this condition also have an increased risk of sudden cardiac death (SCD). Through these projects, Dr Akbari aims to improve how clinicians predict risk and understand disease progression in DCM.
The first project aims to develop and validate a model to predict a patient’s five-year risk of sudden cardiac death and major ventricular arrhythmias using routinely available clinical information. The project will also incorporate cardiac imaging and genetic data to improve predictive accuracy and will be validated in both prospective and real-world patient cohorts.
The second project will use electronic health record data to model disease progression and develop a multimodal risk score to predict major ventricular arrhythmias and sudden cardiac death. The research will also explore whether machine learning can help predict how individual patients respond to medication, helping clinicians tailor treatments more effectively and potentially reduce unnecessary interventions.
The BMA funding will allow Dr Akbari to advance these important research projects while continuing to contribute to patient care through his clinical practice.
Commenting on the awards, Dr Akbari said:
“I am honoured to receive both grants, which will support much-needed research into patient-identified unmet needs in dilated cardiomyopathy using state-of-the-art technologies.
“I am sincerely grateful to the BMA Research Foundation for these awards, and I extend my heartfelt thanks to my supervisors, colleagues, and family for their unwavering support”
